Large-scale testing (Phase 3)Study completedNCT01510158What this trial is testingCombining Lesinurad With Allopurinol in Inadequate RespondersWho this might be right forGout Ardea Biosciences, Inc. 607
Not applicableStudy completedNCT01867840What this trial is testingRole of ASICs in Human Inflammatory PainWho this might be right forArthritisOsteoarthritisChondrocalcinosis+2 more Centre Hospitalier Universitaire de Nice 20
Not applicableStudy completedNCT04519021What this trial is testingKnowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in NepalWho this might be right forGout National Center for Rheumatic Diseases, Nepal 380
Not applicableStudy completedNCT05289544What this trial is testingPhone-Based Based Walk With Ease Program for Adults With ArthritisWho this might be right forArthritisGoutFibromyalgia+3 more University of South Carolina 267
Not applicableUnknownNCT04306653What this trial is testingACTH vs Betamethasone in Hospitalized Patients With Acute GoutWho this might be right forGout Attack University of Patras 60
Testing effectiveness (Phase 2)Study completedNCT02246673What this trial is testingRDEA3170 and Febuxostat Combination Study in Gout SubjectsWho this might be right forGout Ardea Biosciences, Inc. 64
Not applicableActive Not RecruitingNCT04075903What this trial is testingGout in the ED and Improving Research ParticipationWho this might be right forGout University of Alabama at Birmingham 200
Large-scale testing (Phase 3)Study completedNCT01470989What this trial is testingΒ-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3)Who this might be right forAcute Gouty Arthritis Flares Novartis Pharmaceuticals 136
Testing effectiveness (Phase 2)Study completedNCT02287818What this trial is testingAC-201 Controlled-Release Tablet (CR Tablet) in Patients With GoutWho this might be right forGout TWi Biotechnology, Inc. 127
Post-approval studies (Phase 4)WithdrawnNCT02995512What this trial is testingMechanistic Effects of Colchicine in Patients With Myocardial InfarctionWho this might be right forMyocardial Infarction NYU Langone Health
Early research (Phase 1)Study completedNCT03857165What this trial is testingPlacebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout PatientsWho this might be right forGout, Hyperuricemia Shanton Pharma Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT00170781What this trial is testingEfficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of GoutWho this might be right forAcute Gouty Arthritis Novartis 234
Not applicableStudy completedNCT02393560What this trial is testingDECT Study in Allopurinol-Treated Gout PatientsWho this might be right forGout Ardea Biosciences, Inc. 223
Early research (Phase 1)Study completedNCT03291782What this trial is testingD-0120 Safety and PK/PD, Food Effect Study in Healthy VolunteersWho this might be right forGout InventisBio Co., Ltd 39
Testing effectiveness (Phase 2)UnknownNCT06270225What this trial is testingSSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.Who this might be right forGout Arthritis Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 157
Large-scale testing (Phase 3)Study completedNCT05818085What this trial is testingPhase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With GoutWho this might be right forGout Atom Therapeutics Co., Ltd 300
Testing effectiveness (Phase 2)Study completedNCT03923868What this trial is testingD-0120 Safety and PK/PD Study in ChinaWho this might be right forHyperuricemia or Gout InventisBio Co., Ltd 52
Large-scale testing (Phase 3)Active Not RecruitingNCT07414394What this trial is testingTigulixostat (IBI128) vs Febuxostat in GoutWho this might be right forGout Innovent Biologics Technology Limited (Shanghai R&D Center) 600
Testing effectiveness (Phase 2)Ended earlyNCT04067492What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Doses to Patients With Acute Gout AttackWho this might be right forGout Attack R-Pharm 47
Large-scale testing (Phase 3)Study completedNCT02578394What this trial is testingAnakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility StudyWho this might be right forGoutChronic Kidney Diseases Mid and South Essex NHS Foundation Trust 21